IGC Pharma Inc. held its Annual Meeting of Stockholders on October 10, 2025. Stockholders approved the election of Ram Mukunda and James Moran to the board of directors. The appointment of Manohar Chowdhry & Associates as the independent registered public accounting firm for the 2026 fiscal year was ratified. Approval was also given for the grant of 5,000,000 shares of common stock to be awarded from time to time to current and new employees, advisors, directors, and consultants, based on certain metrics. Additionally, an amendment to increase the authorized number of shares of common stock from 150,000,000 to 600,000,000 was approved.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IGC Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001185185-25-001428), on October 14, 2025, and is solely responsible for the information contained therein.